Achieve Life Sciences Inc (ACHV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
Sales | 4,929 | 11,731 | 8,604 | 9,862 | 6,340 |
Gross Profit | 4,929 | 11,731 | 8,604 | 9,862 | 6,340 |
Operating Expenses | 12,559 | 19,660 | 15,641 | 20,477 | 15,736 |
Operating Income | -7,630 | -7,929 | -7,037 | -10,615 | -9,396 |
Other Income | 615 | -707 | 359 | 561 | 976 |
Pre-tax Income | -7,015 | -8,636 | -6,678 | -10,054 | -8,420 |
Net Income Continuous | -7,015 | -8,636 | -6,678 | -10,054 | -8,420 |
Net Income | $-7,015 | $-8,636 | $-6,678 | $-10,054 | $-8,420 |
EPS Basic Total Ops | -1,034.10 | -1,298.13 | -1,012.10 | -1,496.15 | -1,254.13 |
EPS Basic Continuous Ops | -1,029.79 | -1,290.66 | -999.23 | -1,505.75 | -1,262.50 |
EPS Diluted Total Ops | -1,034.10 | -1,298.13 | -1,012.10 | -1,496.15 | -1,254.13 |
EPS Diluted Continuous Ops | -1,029.79 | -1,290.66 | -999.23 | -1,505.75 | -1,262.50 |
EBITDA(a) | $-7,575 | $-7,874 | $-6,972 | $-10,553 | $-9,340 |